XML 34 R6.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Related Party
Nonrelated Party
Warrants Issued, Debt Offering
Warrants Issued, Equity Offering
Series A Preferred Stock
Preferred Stock
Preferred Stock
Series A Preferred Stock
Common Stock
Common Stock
Related Party
Common Stock
Nonrelated Party
Additional Paid-in Capital
Additional Paid-in Capital
Related Party
Additional Paid-in Capital
Nonrelated Party
Additional Paid-in Capital
Warrants Issued, Debt Offering
Additional Paid-in Capital
Warrants Issued, Equity Offering
Treasury Stock
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Beginning balance, preferred (in shares) at Dec. 31, 2021               0                        
Beginning balance at Dec. 31, 2021 $ 123,179             $ 0   $ 100     $ 218,762         $ 0 $ (95,683)  
Beginning balance (in shares) at Dec. 31, 2021                   99,976,253                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                        
Issuance of Series A Convertible Preferred Stock, net of issuance costs (in shares)                 9,566                      
Convertible promissory notes converted to common stock             $ 9,273   $ 9,273                      
Warrant offerings         $ 8,315 $ 5,700                   $ 8,315 $ 5,700      
Stock-based compensation expense 1,568                       1,568              
Warrant exercise (in shares)                   5,714,823                    
Warrant exercise 58                 $ 6     52              
Modifications to embedded conversion feature of convertible promissory notes 1,592                       1,592              
Common stock offering, net of issuance costs (in shares)                   39,801,895                    
Common stock offering, net of issuance costs 58,860                 $ 39     58,821              
Net loss (90,791)                                   (90,791)  
Ending balance, preferred (in shares) at Dec. 31, 2022               9,566                        
Ending balance at Dec. 31, 2022 117,754             $ 9,273   $ 145     294,810         0 (186,474)  
Ending balance (in shares) at Dec. 31, 2022                   145,492,971                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                        
Issuance of Series A Convertible Preferred Stock, net of issuance costs (in shares)                   11,762,956                    
Convertible promissory notes converted to common stock 4,705                 $ 12     4,693              
Common stock reacquired in exchange for warrants (in shares)                   (12,000,000)                    
Common stock reacquired in exchange for warrants (12,491)                 $ (12)     (12,479)              
Warrant issuance in conjunction with debt modification 16,036                       16,036              
Warrant offerings 14,991                       14,991              
Warrant exercise (in shares)                   25,871,539                    
Warrant exercise 3,527                 $ 27     3,500              
Common stock offering, net of issuance costs (in shares)                   99,136,670                    
Common stock offering, net of issuance costs $ 132,542                 $ 98     132,444              
Common stock issued for share based liabilities due to related party & stock-based compensation expense and issuance of stock (in shares)                     2,460,513 5,586,736                
Common stock issued for share based liabilities due to related party & stock-based compensation expense and issuance of stock     $ 15,000 $ 5,859             $ 2 $ 5   $ 14,998 $ 5,854          
Tax withholdings related to net share settlements of stock-based compensation awards (in shares) (1,578,056)                 (1,578,056)                    
Tax withholdings related to net share settlements of stock-based compensation awards $ (2,013)                       (2,013)              
Net loss $ (73,421)                                   (73,421)  
Ending balance, preferred (in shares) at Dec. 31, 2023 9,566             9,566                        
Ending balance at Dec. 31, 2023 $ 222,489 $ 37           $ 9,273   $ 277     472,834         0 (259,895) $ 37
Ending balance (in shares) at Dec. 31, 2023 276,733,329                 276,733,329                    
Beginning balance, preferred (in shares) at Dec. 31, 2023 9,566             9,566                        
Beginning balance at Dec. 31, 2023 $ 222,489 $ 37           $ 9,273   $ 277     472,834         0 (259,895) $ 37
Beginning balance (in shares) at Dec. 31, 2023 276,733,329                 276,733,329                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                        
Warrant exercise (in shares)                   31,853,909                    
Warrant exercise $ 4,808                 $ 32     4,776              
Common stock offering, net of issuance costs (in shares)     1,083,189             67,368,125                    
Common stock offering, net of issuance costs 189,213   $ 2,500             $ 67     189,146              
Common stock issued for share based liabilities due to related party & stock-based compensation expense and issuance of stock (in shares)                     1,083,189 12,241,621                
Issuance of stock for stock-based compensation/liabilities     $ 2,500 $ 30,927             $ 1 $ 7   $ 2,499 $ 30,920          
Common stock issued for new ground lease to related party (in shares)                   20,000,000                    
Common stock issued for new ground lease to related party 68,760                 $ 20     68,740              
Purchase of capped call (60,000)                       (60,000)              
Treasury stock repurchased $ (118,217)                                 (118,217)    
Tax withholdings related to net share settlements of stock-based compensation awards (in shares) (5,057,145)                 (5,057,145)                    
Tax withholdings related to net share settlements of stock-based compensation awards $ (23,654)                       (23,654)              
Net loss $ (72,418)                                   (72,418)  
Ending balance, preferred (in shares) at Dec. 31, 2024 9,566             9,566                        
Ending balance at Dec. 31, 2024 $ 244,445             $ 9,273   $ 404     $ 685,261         $ (118,217) $ (332,276)  
Ending balance (in shares) at Dec. 31, 2024 404,223,028                 404,223,028